Rationale and design of a multi-center, prospective randomized controlled trial on the effects of sacubitril-valsartan versus enalapril on left ventricular remodeling in ST-elevation myocardial infarction: The PERI-STEMI study.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical cardiology"
DOI: 10.1002/clc.23744
Abstract: BACKGROUND Angiotensin receptor neprilysin inhibitor (ARNI) sacubitril-valsartan has been recommended as one of the first-line therapies in heart failure with reduced ejection fraction. However, whether ARNI could benefit patients with ST-segment elevation myocardial infarction (STEMI)… read more here.
Keywords: trial; sacubitril valsartan; enalapril; elevation myocardial ... See more keywords